Blue Owl Capital Inc.
OWL
Market read
Blue Owl Capital Inc.'s move is spreading beyond its market group.
OWL accounts for 9.7% of the group's measured movement across 8.4 effective names. raw member direction is mixed; 9 of 10 SPY-adjusted paths align to the downside. Capital-flow agreement is 23%, so confirmation is not yet clean. No verified headline preceded the measured group move.
Is this move genuinely shared?
OTF, ARCC, HTGC moved materially before OWL. OWL crossed its material path threshold at 10:05 ET. BXSL, TSLX, MAIN followed.
8 of 10 members in Biopharmaceuticals and Care are active. 0 of 8 disclosed connections are confirming.
- At least 7 of 10 members remain active in the next snapshot.
- Capital-flow agreement rises above 55%.
- FNF remains aligned with the group in the next market snapshot.
Invalidation: The live read weakens if participation falls to 3 of 10 members or fewer.
Research brief
The story so far
OWL accounts for 9.7% of the group's measured movement across 8.4 effective names. raw member direction is mixed; 9 of 10 SPY-adjusted paths align to the downside. Capital-flow agreement is 23%, so confirmation is not yet clean. No verified headline preceded the measured group move.
No thresholded supportive filing evidence is available yet.
No thresholded adverse filing evidence is available yet.
- At least 7 of 10 members remain active in the next snapshot.
- Capital-flow agreement rises above 55%.
- FNF remains aligned with the group in the next market snapshot.
Price action
How the market is pricing the story
Jodie does not have enough daily observations to draw a useful short-term chart for this asset. The latest quoted price was checked 2 Oct, 15:55 GMT-4; this is a coverage limitation, not a flat-price conclusion.
Developments
No sourced recent-development timeline yet
Jodie has not returned a relevant primary source or news item for OWL. This is an evidence-coverage gap, not a conclusion that nothing material happened.
Business and financial condition
Reported financial figures are not available yet
Jodie has not returned structured SEC XBRL fundamentals for this asset. This is a coverage limitation, not an assessment of the business or its financial health.
Filing analysis
No comparable filing assessment is available yet
Jodie has not yet found a suitable current-versus-prior filing comparison for OWL. This does not mean the latest filing was neutral or immaterial.
Business ecosystem
The relationships behind OWL
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
CBOECboe Global Markets, Inc.competitorMay 1, 2026 ▾
“The CBOE Volatility Index peaked above 30 during the first quarter of 2026, its highest level since April 2025.”
Depended on by
OTFBlue Owl Technology Finance Corp.partnerNov 5, 2025 ▾
“Joint Ventures On May 6, 2024, Credit SLF, a Delaware limited liability company, was formed as a joint venture between us, Blue Owl Capital Corporation, Blue Owl Capital Corporation II, Blue Owl Credit Income Corp., Blue Owl Technology Income Corp., and State…”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 11 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
OWL is currently a Participant in the organic co-movement group Biopharmaceuticals and Care. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 2 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.
Context history
Theme membership history
No durable theme membership has been observed for this name yet.